Foresite Capital Management IV’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,382,641	Closed	-$85.1M	–	15
2021 Q1	$85.1M	Sell	1,382,641 -30,064	-2%	-$1.85M	10.19%	4
2020 Q4	$99.7M	Hold	1,412,705	–	–	10.82%	2
2020 Q3	$54.5M	Sell	1,412,705 -15,366	-1%	-$593K	12.29%	3
2020 Q2	$53.6M	Buy	+1,428,071	New	+$53.6M	26.09%	1